Companies: 10,795·Total market cap: $144.5T

Gemini Therapeutics, Inc.

Gemini Therapeutics, Inc.

GMTXNASDAQHealthcare

$1.35

+$0.00(+0.00%)

Market Cap$25491780

P/E Ratio—

52W High$24.7

52W Low$1.35

Avg Volume19K

Open$1.36

Beta0.00

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Gemini Therapeutics, Inc.（GMTX）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · GMTX · 截至 Jun 9, 2026

关键指标

EPS (TTM)—Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)—Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding—Shares outstanding history

Next EarningsTBAEarnings history

探索 Gemini Therapeutics, Inc. 数据

分析师预测$— · Buy

股息不分红

分析师评级与目标价

Buy1 位分析师

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$1.35Current

$—Avg Target

$—High

合计: 1 · 买入占比: 100.0%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Gemini Therapeutics, Inc.

$1.35+0.00%$25.5M #2

$0.33+0.22%$29.7M #3

Angion Biomedica Corp.

$1.00+0.00%$30.1M #4

AnPac Bio-Medical Science Co., Ltd.

$4.30-3.15%$27.0M #5

Elevation Oncology, Inc.

$0.37-2.12%$21.6M #6

Freeline Therapeutics Holdings plc

$6.49+0.15%$28.3M

股票表现

1D+0.00%

1W-94.10%

1M-92.90%

3M-91.96%

YTD-92.48%

1Y-91.82%

5Y-86.89%

关于 Gemini Therapeutics, Inc.

CEO—

IPO DateAug 12, 2020

Employees24

CountryUS

Websitegeminitherapeutics.com

Gemini Therapeutics, Inc. operates as a clinical-stage precision medicine enterprise, dedicated to crafting various therapeutic solutions for age-related macular degeneration (AMD) with a genetic foun…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Gemini Therapeutics, Inc.（GMTX）是 Biotechnology 行业的 Healthcare 类公司，于 Aug 12, 2020 在 NASDAQ 上市。截至最近交易日，GMTX 股价为 $1.35，市值约为 $25.5M。过去12个月累计回报 -91.82%，年初至今回报 -92.48%。

常见问题

截至最近一个交易日，Gemini Therapeutics, Inc.（GMTX）股价为 $1.35，在 NASDAQ 上市，52周区间为 $1.35 – $24.70。

GMTX 最新股价GMTX quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议